Biomarkers to Detect Endocrine Therapy Resistance
Conditions: Metastatic Cancer; Breast Cancer; Lobular Breast Carcinoma Interventions: Drug: 18F-fluorofuranylnorprogesterone; Device: Liquid Biopsy; Device: Positron Emission Tomography/Computed Tomography Sponsors: University of Wisconsin, Madison Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | CT Scan | Endocrine Therapy | PET Scan | Research | University of Wisconsin